#3110
Kim Hyun-tae
50 years old Self-Made
Overview
- Source of Wealth
- Biotech
- Residence
- Incheon
- Education
- Seoul National University (Bachelor of Business Administration)Seoul National University (Master of Business Administration)
- Marital Status
- Married
Biography
Kim Hyun-tae is CEO of South Korean biotechnology company Voronoi.
Voronoi's two most promising cancer drug candidates are VRN10 and VRN11. Both started Phase 1 clinical trials in the first quarter of 2025.
Voronoi was founded by Kim's younger brother, Hyun-seok, in 2015. The older Kim took over the company in 2016 and listed it on Korea's Kosdaq in 2022.
Previously, Kim did stints as head of asset management at eBest Investment & Securities, Hanwha Investment & Securities and KB Securities.